September 18 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its CEO Ognyan Donev has acquired 3,449 shares in the company at a weighted average price per share of 3.419 levs ($1.93/1.75 euro).